Is Cenobamate the Breakthrough We Have Been Wishing for?

Is Cenobamate the Breakthrough We Have Been Wishing for?

Close to one-third of patients with epilepsies are refractory to current anti-seizure medications; however, trials with cenobamate suggest effectiveness in such patients with focal onset seizures. We searched for data published or otherwise reported on cenobamate and outlined these here. Despite bei...

Full description

Bibliographic Details
Main Authors:	Nicola Specchio, Nicola Pietrafusa, Federico Vigevano
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	International Journal of Molecular Sciences
Subjects:	cenobamate drug-resistant epilepsy anti-seizure medications (ASMs) clinical trials epilepsy
Online Access:	https://www.mdpi.com/1422-0067/22/17/9339

Similar Items

Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence?
by: Nicola Pietrafusa, et al.
Published: (2023-12-01)

Safety and efficacy of cenobamate in patients with uncontrolled focal seizures - a review of the literature
by: Zofia Pietrzak, et al.
Published: (2022-02-01)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
by: Konstantin L. Makridis, et al.
Published: (2022-07-01)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
by: Bettina Schmitz, et al.
Published: (2023-12-01)

Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
by: Jamir Pitton Rissardo, et al.
Published: (2023-07-01)

Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
by: Giovanni Falcicchio, et al.
Published: (2022-12-01)

Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction
by: Anna-Lena Friedo, et al.
Published: (2023-07-01)

Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABA<sub>A</sub> Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications
by: Dustin R. Latimer, et al.
Published: (2021-06-01)

Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy
by: Judit Catalán‐Aguilar, et al.
Published: (2024-02-01)

Cenobamate is an effective treatment for drug resistance focal epilepsy: a critical review
by: Jayasheela S Hiremath, et al.
Published: (2023-01-01)

The Theoretical Description for Cenobamate CuS-Assisted Electrochemical Determination in Pharmaceutical Formulations and Wastewater
by: Volodymyr Tkach, et al.
Published: (2024-01-01)

Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database
by: Shihao Chen, et al.
Published: (2024-03-01)

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
by: Zaccara G, et al.
Published: (2021-11-01)

Editorial: The molecular mechanisms of epilepsy and potential therapeutics
by: Tobias Engel, et al.
Published: (2022-11-01)

Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry
by: Linda Molteni, et al.
Published: (2024-02-01)

Development of a stability indicating high-performance liquid chromatography method for determination of cenobamate: study of basic degradation kinetics
by: Samah F. EL-Malla, et al.
Published: (2024-04-01)

Perampanel during pregnancy: Description of four cases
by: A.M. Alicino, et al.
Published: (2021-01-01)

Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy
by: Ayataka Fujimoto, et al.
Published: (2022-08-01)

Impact of epilepsy and its treatment on brain metastasis from solid tumors: A retrospective study
by: Marta Maschio, et al.
Published: (2022-10-01)

The Occurrence and Relationship of Postoperative Seizure and de novo Epilepsy after Craniotomy Surgery: A Retrospective Single-Center Cohort Study
by: Sayaka Horiuchi, et al.
Published: (2022-04-01)

The Occurrence of Seizure Clusters in Patients With Epilepsy Is Partly Determined by Epilepsy Severity: A Single-Center Retrospective Observational Study
by: Rui Zhong, et al.
Published: (2021-12-01)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
by: Gianluca Dini, et al.
Published: (2022-05-01)

Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
by: Susan M. Melnick, et al.
Published: (2023-08-01)

Governance of the clinical pathway and management of the patient suffering from epilepsy and drug-resistant epilepsy
by: Angela La Neve, et al.
Published: (2022-06-01)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
by: Gianluca Dini, et al.
Published: (2023-01-01)

The impact of epilepsy and antiseizure medications on pregnancy and neonatal outcomes: A nationwide cohort study
by: Cheng‐Yen Kuo, et al.
Published: (2023-12-01)

Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
by: Francesca Bosco, et al.
Published: (2023-08-01)

The 50th anniversary of the Italian League Against Epilepsy (Lega Italiana Contro l’Epilessia)
by: Laura Tassi, et al.
Published: (2022-01-01)

Refractory Status Epilepticus in Genetic Epilepsy—Is Vagus Nerve Stimulation an Option?
by: Nicola Specchio, et al.
Published: (2020-06-01)

The evolution of the concepts of seizures and epilepsy: What’s in a name?
by: Puja Patel, et al.
Published: (2020-03-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
by: Michel Mandro, et al.
Published: (2020-03-01)

Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
by: Nicola Specchio, et al.
Published: (2020-08-01)

Clinical characteristics and diagnoses of 1213 children referred to a first seizure clinic
by: Geertruida Slinger, et al.
Published: (2024-04-01)

Non-vitamin K Oral Anticoagulants and Anti-seizure Medications: A Retrospective Cohort Study
by: Chen-Jui Ho, et al.
Published: (2021-02-01)

Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples
by: Bruno Charlier, et al.
Published: (2022-10-01)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
by: Renzo Guerrini, et al.
Published: (2022-12-01)

Extreme late onset of genetic generalized epilepsy in older adults and the elderly: A cohort study and literature review
by: Majed Alzahrany, et al.
Published: (2023-03-01)

Drug resistant epilepsy and associated factors among children with epilepsies in Tanzania: a cross-sectional study
by: Obrey H Urio, et al.
Published: (2024-01-01)

Effectiveness and safety of adjunctive cenobamate for focal seizures in adults with developmental disability treated in clinical practice
by: Gregory S. Connor, et al.
Published: (2022-01-01)

Early epilepsy surgery for non drug-resistant patients
by: Veronica Pelliccia, et al.
Published: (2022-01-01)